Guidelines

On the eve of World AIDS Day (Dec. 1), Johnson & Johnson announced that its Janssen Pharmaceutical Companies together with a consortium of global partners have initiated the first efficacy study for an investigational mosaic HIV-1 preventive vaccine.

The Bill & Melinda Gates Foundation and National Institutes of Health are joining forces with Johnson & Johnson to advance the potential prevention option, which is designed to be a “global vaccine” that could prevent a wide range of viral strains responsible for the HIV pandemic.

Officials at AholdUSA are quite proud of the success of their health screening program. And with good reason. In 2017 alone, the company reports that it provided nearly 36,000 health screenings and more than 20,000 immunization recommendations to roughly 14,000 patients. All of this was done at no charge to the customers, officials note.

Allergens are widespread, but highly variable in U.S. homes, according to the nation’s largest indoor allergen study to date. Researchers from the National Institutes of Health on Thursday reported that more than 90% of homes had three or more detectable allergens, and 73% of homes had at least one allergen at elevated levels.

With the increasing trend of self-management and the rising awareness around the diabetes disease state within developing countries, blood glucose meters can be utilized to aid in adjustment of therapeutic regimen in response to blood glucose values and to help patients adjust their dietary intake, physical activity and insulin doses to improve glycaemic control on a regular basis.

This and several other factors are covered in the latest Research and Marekts report focused on diabetes care devices.

With flu season set to kick into gear soon, CVS Health is marking National Influenza Vaccination Week by reminding patients to get their flu shots. The Centers for Disease Control and Prevention established the week of awareness to remind patients to get vaccinated. The Woonsocket, R.I.-based company recently ran a survey that found that 61% of patients get a flu vaccine every year, or plan to get one this year.

Upsher-Smith, the Maple Grove, Minn.-based subsidiary of Japan’s Sawai Pharmaceuticals, has re-introduced its Klor-Con (potassium chloride for oral solution). The company received approval from the Food and Drug Administration for the product that joins its generics portfolio. The company noted that the relaunched product would be available with a new NDC number.

The product has a U.S. market size of $98 million for the 12 months ended September 2017, according to data from IQVIA.

The Centers for Medicare and Medicaid Services recently shared its proposed changes to Medicare Part D, and it includes several measures that the industry has been seeking. The proposed rule includes changes regarding e-prescribing and medication therapy management, addressing opioid abuse and building pharmacy access, the National Association of Chain Drug Stores said.